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Abstract
Background: Previously, we found that interleukin (IL)-18 deficiency aggravates kainic acid (KA)-induced hippocampal 
neurodegeneration in young C57BL/6 mice due to an over-compensation by IL-12. Additionally, IL-18 participates in 
fundamental inflammatory processes that increase during aging. In the present study, we were interested in the role of 
IL-18 in KA-induced neurodegeneration in aged female C57BL/6 mice.
Methods: Fifteen aged female IL-18 knockout (KO) and 15 age-matched wild-type (WT) mice (18 to 19 months old) 
were treated with KA at a dose of 25 mg/kg body weight intranasally. Seizure activities and behavioral changes were 
rated using a 6-point scoring system and open-field test, respectively. Seven days after KA treatment, degenerating 
neurons were detected by Nissl's method and Fluoro-Jade B staining; and microglial activation was analyzed by 
immunohistochemistry and flow cytometry.
Results: Aged female IL-18 KO and WT mice showed similar responses to treatment with KA as demonstrated by 
comparable seizure activities, behavioral changes and neuronal cell death. However, aged female IL-18 KO mice failed 
to exhibit the strong microglial activation shown in WT mice. Interestingly, even though the number of activated 
microglia was less in KA-treated IL-18 KO mice than in KA-treated WT mice, the proportion of microglia that expressed 
the cytokines tumor necrosis factor (TNF)-α, IL-6 and IL-10 was higher in KA-treated IL-18 KO mice.
Conclusion: Deficiency of IL-18 attenuates microglial activation after KA-induced excitotoxicity in aged brain, while the 
net effects of IL-18 deficiency are balanced by the enhancement of other cytokines, such as TNF-α, IL-6 and IL-10.
Background
Administration of kainic acid (KA), an analog of the exci-
totoxin glutamate, to rodents results in neuronal death
and seizures [1], which provides a well-characterized
model for studies of human neurodegenerative diseases
[2-4]. Synthesis and release of cytokines and other
inflammatory factors by glial cells influence the survival
and repair of hippocampal neurons after injury [5,6].
Interleukin (IL)-18, first isolated as interferon-γ induc-
ing factor [7], is related to the IL-1 family by mechanism
of origin, receptor structure, and signal transduction
pathways utilized [8]. IL-18 serves as a link between
innate and adaptive immune responses, through mecha-
nisms such as stimulating the expression of adhesion
molecules, inducing the production of chemokines (IL-8)
and cytokines (tumor necrosis factor and IL-6), stimulat-
ing the activity of NK cells, stimulating the expression of
Fas ligand on T and NK cells and the cytotoxic activity of
CD8+ effector T cells, stimulating Th1 responses in com-
bination with IL-12, stimulating Th2 responses in combi-
nation with IL-2, and stimulating Th17 responses in
combination with IL-23 [9]. IL-18 and IL-18 receptor (IL-
18R) mRNA have been detected in brain tissue from
adult rats and in cultured astrocytes and microglia
[10,11]. However, the effects of IL-18 in neurodegenera-
tion are complicated. Our previous study showed that
young (six to eight weeks old) IL-18 knockout (KO) mice
were more sensitive to KA administration than wild-type
(WT) animals with normal expression of IL-18, although
exogenous IL-18 administration could aggravate KA-
induced neurodegeneration [12].
We also found that aged female mice were more sus-
ceptible to KA-induced excitotoxicity than male mice,
which resembles the situation for humans [13]. It has also
been suggested that IL-18 participates in fundamental
inflammatory processes that increase during aging [14].
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role of IL-18 in KA-induced neurodegeneration in aged
female C57BL/6 mice. Our results demonstrate that defi-
ciency of IL-18 attenuates microglial activation after KA-
induced excitotoxicity in aged brain.
Methods
Animals
Fifteen aged female IL-18 KO and 15 age-matched
C57BL/6 WT mice (18 to 19 months old) were used in
the present study. The mice were purchased from the
Jackson Laboratory (Bar Harbor, ME, USA) at age of 2
months and kept at the animal facilities of Karolinska
University Hospital, Huddinge, Sweden until the
designed ages for experiments. All mice were housed on a
12 h light-dark schedule with water and food available ad
libitum. The KA-induced excitotoxic model in mice was
approved by the South Stockholm Research Animal Eth-
ics Committee, Huddinge County Court, Stockholm,
Sweden. All efforts were made to minimize the number of
animals used and their sufferings.
KA administration and assessment of seizure activity
Mice were partially anesthetized with Isoflurane (Abbott
Laboratories, Kent, UK) and held on their backs by hand.
KA, (Opika-1, Ocean Produce International, Shelburne,
Nova Scotia, Canada) dissolved in saline, (10 mg/1.3 ml)
was slowly and gently dropped by micropipette into the
nostrils of the mice at a dose of 25 mg/kg body weight as
described previously [15]. Four IL-18 KO mice and 5 WT
mice were administrated with physiological saline as con-
trol. Mice were observed by two different examiners con-
tinuously for 5 hours to record the onset and extent of
seizure activity. Seizures were rated according to the cri-
teria described by Ben-Ari [16] with modifications: 0,
normal; 1, immobilization; 2, rearing and falling; 3, sei-
zure for less than 1 h; 4, seizure for 1-3 h; 5, seizure for
more than 3 h; and 6, death.
Open-field test with zone monitoring
Open-field activity was measured one day before and six
days after KA administration in 8 IL-18 KO mice and 7
WT mice. The open field test was used to measure
exploratory behaviour and spontaneous motor activity of
the animals. The apparatus consisted of four identical
Plexiglas boxes (34 × 34 × 18 cm) with a lower and a
higher row of infrared sensitive photocells connected to a
computer that registered the interruptions of these cells
which corresponded to the horizontal and vertical activi-
ties of the animals inside of the arena. Light bulbs (25 W)
provided the illumination for each arena. Four mice were
tested simultaneously, one per arena. At the beginning
each mouse was placed into the center of open-field
arena and its movement was recorded every 5 min during
60 min. The overall locomotion and the number of times
the animal lifted its fore paws and stood on its back feet
(rearing) were analyzed. All tests were carried out
between the hours of 9:00 and 15:00.
Histopathological analysis
All mice were anesthetized with sodium pentobarbital
and transcardially perfused with phosphate-buffered
saline (PBS) seven days after the administration of KA.
The left hemisphere of each brain was fixed in 4% para-
formaldehyde and kept in 10% sucrose until being frozen,
and the right hippocampus was dissociated and put into
Krebs-Ringer buffer (KRB) solution [120 mM NaCl, 5
mM KCl, 1.2 mM KH2PO4, 25 mM NaHCO3, 14 mM D-
glucose, 2.5 mM MgSO4, 0.3% bovine serum albumin
(BSA)] for isolation and flow cytometric analysis of
microglia. Coronal sections (12-μm slices) from -1.15, -
1.94 and - 2.80 mm, respectively, relative to the bregma
were prepared according to the information in Franklin's
brain atlas [17]. Sections were stained by Nissl's method
and Fluoro-Jade B (FJB) (Histo-Chemo, Inc., Jefferson,
AR) staining to evaluate degenerating neurons. FJB is an
anionic fluorescein derivative useful for the histological
staining of neurons undergoing degeneration. For assess-
ment of severity and extent of neurodegeneration in the
hippocampus after Nissl's staining, sections were scored
using a semiquantitative grading system: 0, normal; 1,
slight shrinkage of neurons (1 - 4% pyknotic neurons in
area CA3); 2, moderate shrinkage of neurons (5 - 15%
pyknotic neurons in area CA3); 3, severe shrinkage of
neurons (more than 15% pyknotic neurons in area CA3);
4, slight loss of neurons (5 - 10% neuron loss in area
CA3); 5, moderate loss of neurons (11 - 40% neuron loss
in area CA3); and 6, severe loss of neurons (more than
40% neuron loss in area CA3). Using a blinded protocol,
two different examiners duplicated the counting.
Immunohistochemistry of brain sections
Frozen hippocampal sections were prepared as described
for histopathological analysis. After washes with Tris buf-
fer, the sections were blocked by "protein block" (DAKO,
Glostrup, Denmark) at room temperature for 30 min.
Subsequently, they were exposed to rat antibodies to
CD11b (1:100, Serotec, Oxford, UK) and rabbit antibod-
ies to glial fibrillary acidic protein (GFAP) (1:2000;
DAKO), respectively, followed by staining with the avi-
din-biotin technique (Vectastain Elite Kit, Vector Labs,
Burlingame, CA, USA). Peroxidase-substrate solution
DAB (Sigma-Aldrich, Stockholm, Sweden) was added
until the desired intensity of yellow color developed.
Omission of primary antibodies served as negative con-
trol. Slides were observed using a Nikon Eclipse E800-U
microscope (Nikon, Japan). Positive immunostaining of
cells was rated using a semiquantitative scale - baseline
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intense response (+ + +) - by two observers, indepen-
dently. Criteria for each scale followed the description by
Colburn et al [18].
Isolation and flow cytometric analysis of microglia
As mentioned above, seven days after KA treatment, the
right hippocampus of each brain was collected and put
into KRB solution for isolation and flow cytometric anal-
ysis of microglia. The hippocampi were dissected and dis-
sociated by pipetting. Next, after trypsinization at 37°C
for 15 min, fetal bovine serum (10%, final concentration)
was added to inactivate trypsin activity. The tissues were
then dissociated with repeated pipetting in KRB solution
containing DNase I (Sigma-Aldrich). Cell suspensions
were passed through a 70-μm pore-size strainer and spun
down. The cell pellets were resuspended in 30% Percoll in
PBS and centrifuged at 500 × g for 20 min. The resulting
pellets were resuspended, passed through a 40-μm pore-
size strainer, collected, and stained for flow cytometry.
Microglia-enriched cell suspensions were washed with
PBS containing 1% BSA (BSA/PBS), permeabilized, fixed
and incubated with the following antibodies: APC-
labeled rat anti-mouse CD11b (Caltag, Burlingame, CA,
USA), either PerCP-labeled rat anti-mouse CD45 (Sero-
tec), RPE-labeled mouse anti-mouse major histocompati-
bility complex (MHC)-II I-Ak (Serotec) and FITC-labeled
rat anti-mouse tumor necrosis factor-α (TNF-α) (Becton
Dickinson Biosciences, San José, CA, USA), or RPE-
labeled rat anti-mouse IL-6 (BD Pharmingen, San Diego,
CA, USA) and FITC-labeled rat anti-mouse IL-10
(Pharmingen). FITC-, RPE-, PerCP (Serotec), and APC-
(Caltag) labeled rat IgG were used as isotype controls to
set the gates. Cell size, granularity, and fluorescence
intensity were measured using FACScalibur flow cytome-
ter (Becton Dickinson). A minimum of 5 × 103 cells were
analyzed with CellQuest software (Becton Dickinson).
Microglia from all four groups (WT mice with or without
KA treatment, and IL-18 KO mice with or without KA
treatment) were collected and analyzed on the same day
with the same cytometer settings.
Data presentation and statistics
The Mann-Whitney U test was used to analyze the clini-
cal, histopathological and immunohistochemical data,
and one-factor analysis of variance (ANOVA) was used to
analyze flow cytometric and behavioral results. Data are
presented as mean ± SD. P < 0.05 was considered as sig-
nificant in all tests. Graphics and calculations were per-
formed using GraphPad PRISM version 5.0 (GraphPad,
USA), and SPSS Version 15.0 (SPSS Inc, USA).
Results
IL-18 deficiency does not affect KA-induced seizure activity 
in aged female mice
Intranasal application of KA (25 mg/kg bodyweight)
induced various clinical symptoms in both IL-18 KO and
WT female mice within 30 min, from behavioral arrest,
facial myoclonus, rearing and falling to severe clonic con-
vulsions. Three mice of each group died of serious sei-
zures including status epilecticus (Table 1). The severity
of seizures did not differ significantly between the two
groups. The medians of clinical scores for the IL-18 KO
and WT mice were 3 (1-5) and 5 (1-6), respectively. Nei-
ther IL-18 KO nor WT mice given saline intranasally
showed any clinical signs.
IL-18 deficiency does not influence KA-induced behavioral 
changes in aged female mice
Six days after KA treatment, IL-18 KO and WT mice
showed a similar habituation profile during a 60-min
Table 1: Survey of seizure activity in mice after KA treatment.
Groups
Seizure Activity Variables KO (n = 11) WT (n = 10)
Tonic/clonic twitching without seizures 4/11 2/10
Seizures < 1 h 2/11 1/10
Seizures 1-3 h 1/11 2/10
Seizures > 3 h 1/11 2/10
Death due to seizures 3/11 3/10
Clinical scores (Medians with percentiles) 3 (1-6) 5 (1-6)
Female IL-18 KO and WT mice, 18 to 19 months of age, were treated with KA at a dose of 25 mg/kg bodyweight intranasally. Mice were 
monitored continuously for 5 h to register the onset and extent of seizure activity. KA treatment resulted in various clinical symptoms in both 
IL-18 KO and WT mice. However, the severity of seizure did not differ significantly between the two groups.
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motion or rearing either in WT or KO mice. Moreover,
there was no significant difference between WT and IL-
18 KO mice either before or after KA delivery, indicating
that IL-18 deficiency does not affect KA-induced sponta-
neous activity and exploratory behaviour in aged female
mice (Fig. 1A and 1B).
Aged female IL-18 KO mice and WT mice show similar KA-
induced hippocampal neurodegeneration
Seven days after KA administration, selective hippocam-
pal neurodegeneration was observed. Most brain regions
showed no neuropathological changes; the exceptions
being the CA3 area of hippocampus, which was consis-
tent with our previous studies [15]. The average histo-
pathological scores at the center (-1.94 mm to bregma) of
the hippocampus are presented in Fig. 2A. Continuous
sectioning showed that samples at three levels (anterior, -
1.15 mm to bregma, middle, -1.94 mm and posterior, -
2.80 mm) demonstrated the same overall changes in the
hippocampus (data not shown). Seven days after KA
treatment, at all three hippocampal levels, IL-18 KO mice
(Fig. 2D) and WT mice (Fig. 2C) exhibited similar
degrees of neurodegeneration. A control group treated
with saline showed no pathological changes in the hip-
pocampus (Fig. 2B). The extent of KA-induced hip-
pocampal neuronal degeneration in IL-18 KO mice and
WT mice was further confirmed using FJB staining (Figs.
2E and 2F). In both IL-18 KO mice and WT mice, FJB-
positive neurons were limited to the CA3 region of the
hippocampus, with no difference between the two groups
of mice.
KA-induced hippocampal astrogliosis is not changed by IL-
18 deficiency in aged female mice
Excitotoxicity causes astrogliosis in brain, which is thus a
feature of KA-induced neurodegeneration in hippocam-
pus. We evaluated astrogliosis by detection of the expres-
sion of GFAP, a marker for astrocytes. Seven days after
KA treatments, GFAP immunoreactivity was similarly
enhanced (mild to moderate response) in the hippocampi
of IL-18 KO (Fig. 3B) and WT mice (Fig. 3A). Reactive
astrocytes were found throughout the hippocampus,
including CA1, CA2, CA3 and the dentate gyrus, and
were particularly prominent in the CA3 area. Very few
reactive astrocytes were found in the hippocampi of
saline-treated mice (Fig. 3C, baseline staining), and nega-
tive controls with omission of the primary antibody
showed no positive staining (Fig. 3D). Positive immunos-
taining of cells was rated using the semiquantitative scale
mentioned in Methods. There was no difference in KA-
induced astrogliosis between the two groups of mice
(data not shown).
IL-18 deficiency attenuates KA-induced microglial 
activation in aged female mice
Microglia are the main effector cells of the immune sys-
tem in the central nervous system (CNS). We evaluated
microglial activation by detection of the expression of
CD11b and MHC-II by immunohistochemistry and flow
cytometry. CD11b can detect both resting and activated
microglia, while strong CD11b-immunreactive microglia
show a marked cellular hypertrophy with thicker and
shorter processes. Seven days after KA delivery, although
both groups of mice exhibited microglial activation, the
number of activated microglia of WT mice (Fig. 4A) was
consistently higher than in IL-18 KO mice (Fig. 4B). Very
few activated microglia were found in the hippocampi of
saline-treated mice (Fig. 4C) and the negative controls
with omission of the primary antibody showed no posi-
tive staining (Fig. 4D).
By flow cytometry, microglia of hippocampi were iden-
tified as a homogeneous population of CD11b positive
cells with low/moderate CD45 staining (CD11b+/
CD45low/moderate cells, Fig. 4E). The possible mac-
rophage contamination was excluded by deletion of the
high CD45 staining cells. Similar to the findings of immu-
Figure 1 Comparisons of locomotion (A) and rearing (B) activity 1 
day before and 6 days after KA administration in IL-18 KO (n = 8) 
and WT (n = 7) aged (18 to 19 months old) female mice. IL-18 defi-
ciency does not influence KA-induced behavioral changes in aged fe-
male mice.
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(MHC-II positive cells) in WT mice was significantly
higher than in the IL-18 KO mice 7 days after KA treat-
ment (Fig. 4F). Before KA treatment, there was no differ-
ence in the numbers of MHC-II positive cells between the
two groups.
Expression of TNF-α, IL-6 and IL-10 is increased in IL-18 KO 
mice after KA treatment
We assessed microglial expression of the cytokines TNF-
α, IL-6 and IL-10 using flow cytometry. The results of
flow cytometric analyses of cytokine expression are
shown as the percentage of cytokine-positive cells in the
CD11b+/CD45low/moderate population. Seven days
after KA treatment, the expression of TNF-α, IL-6 and
Figure 2 Histochemical staining of coronal mouse hippocampal sections (showing CA3 area) of aged female mice after KA treatment. Sec-
tions were prepared 7 days after administration of KA and stained by Nissl's method or with Fluoro-Jade B (FJB) staining. The sections were scored 
using a semi-quantitative grading system as described in the Methods. Histopathological scores are presented in the surviving IL-18 KO mice (n = 8) 
and WT mice (n = 7) (A). There was no difference in pathological changes after KA treatment between IL-18 KO and WT mice. Representative sections 
of both groups of mice are presented (B, saline-treated control WT mice; C, Nissl-stained KA-treated WT mice; D, Nissl-stained KA-treated IL-18 KO mice; 
E, FJB-stained KA-treated WT mice; F, FJB-stained KA-treated IL-18 KO mice). Bars = 100 μm.
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with WT mice (Fig. 5). Before KA treatment, there was
no difference in TNF-α, IL-6 or IL-10 expression between
IL-18 KO and WT mice (data not shown).
Discussion
In the present study, we investigated the role of IL-18 in
the pathogenesis of KA-induced excitotoxic neurodegen-
eration in the aged situation by using IL-18-deficient aged
(18 to 19 months old) mice and age-matched WT mice.
The study was motivated by the fact that most common
neurodegenerative disorders such as Alzheimer's disease
and Parkinson's disease are typically diseases of higher
ages and by the hypothesis that findings of KA-induced
neurodegeneration of young individuals may deviate
from findings in older subjects. Since previously we also
found that aged female C57BL/6 mice were more sensi-
tive to KA treatment than aged male mice [13], we per-
formed this study on female animals.
Our results show that IL-18 deficiency does not influ-
ence susceptibility to KA-induced injury in aged female
mice, since KA-induced seizures, behavioral changes and
histopathological changes including astrogliosis were
similar in IL-18 KO mice and WT controls. However, we
found also that aged IL-18-deficient mice show lower
microglial activation in response to KA than do WT mice
as demonstrated by lower numbers of CD11b-positive
and MHC-II-positive cells. On the other hand, in these
activated microglia the percentages of TNF-α-, IL-6- and
IL-10-positive cells were significantly higher in IL-18 KO
mice than in WT mice. These results are in contrast to
our previous findings in KA-induced excitotoxic neuro-
degeneration of IL-18-deficient young mice [12]. Young
(6 to 8 weeks old) IL-18 KO mice were more sensitive to
KA administration than age-matched animals with nor-
mal expression of IL-18. In that situation we concluded
that excitotoxic injury in IL-18 deficient mice might be
due to overcompensation by other microglia-derived, dis-
ease-promoting factors, of which IL-12 is one candidate.
Our present finding that aged IL-18 KO mice display sim-
ilar susceptibility to KA treatment as WT mice might be
due to the balancing influence of other microglia-derived
cytokines such as TNF-α, IL-6 and IL-10.
Figure 3 GFAP expression in hippocampi of aged female mice detected by immunohistochemistry. GFAP positive cells were shown as dark 
brown in color. Seven days after KA treatment, the intensity of GFAP staining in IL-18 KO mice (B) was similar to that in WT mice (A) with similar neu-
ropathological changes. Very few reactive astrocytes were found in the hippocampi of saline-treated mice (C) and negative controls, with omission 
of the primary antibody, showed no positive staining (D). Bars = 100 μm.
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nous IL-18 administration could aggravate KA-induced
neurodegeneration, when high doses of IL-18 are applied
[12]. A recent study of Jeon and co-workers gave hints in
the same direction by showing that levels of IL-18 and its
receptor in hippocampal homogenates increased from
day 1 post-KA onward [19]. Other researchers have found
that lower IL-18 concentrations are associated with
improved activities of daily living in 65- to 80-year-old
men, suggesting that IL-18 might play an active role in
age-related functional impairment [20]. Moreover,
increased hippocampal concentrations of the proinflam-
Figure 4 CD11b and MHC-II expression in hippocampi of aged female mice detected by immunohistochemistry and flow cytometry. Seven 
days after KA treatment, the number of activated microglia was greater in WT mice (A) than in IL-18 KO mice (B) with similar neuropathological chang-
es. Very few activated microglia were found in the hippocampi of saline-treated mice (C) and negative controls with omission of the primary antibody 
showed no positive staining (D). CD11b positive cells were shown as dark brown in color. By flow cytometry, microglia of hippocampi were identified 
as a homogeneous population of CD11b+/CD45low/moderatecells (E). The proportion of MHC-II positive cells was higher in WT mice (n = 5) than in IL-18 
KO mice (n = 6) after KA treatment. Before KA delivery, there was no difference of MHC-II positive cells between the two groups (F). *P < 0.05. Bars = 
100 μm.
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nied by deficits in long-term potentiation in older rats
[21]. The imbalance between pro-inflammatory and anti-
inflammatory cytokines in the aged brain significantly
contributes to age-related deficits in synaptic function
[22].
Upon neuronal injury, microglia, as the main effector
cells of the immune system in the CNS, acquire changes
in morphology and expression of surface antigens and
soluble molecules [23]. In the present study, lower KA-
induced microglial activation in the hippocampi of aged
IL-18 KO mice was found compared with WT as
detected by immunohistochemistry and flow cytometry.
This finding is in agreement with studies of Sugama and
co-workers, who found that stress-induced microglial
activation is reduced in IL-18 KO mice [24]. IL-18 null
mice also show diminished microglial activation and
reduced dopaminergic neuron loss following acute 1-
methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment
[25]. Interestingly, even though the number of activated
microglia is smaller in KA-treated IL-18 KO mice than in
KA-treated WT mice, the proportion of microglia cells
that express the cytokines TNF-α, IL-6 and IL-10 is
higher in the KA-treated IL-18 KO mice, which may
account for the similar neuropathological and clinical
outcome of the IL-18-deficient, aged mice.
Conclusion
This study demonstrates that deficiency of IL-18 attenu-
ates microglial activation in KA-induced excitotoxicity in
aged brain, while the net effects of IL-18 are balanced by
other cytokines, such as TNF-α, IL-6 and IL-10. IL-18
may participate in KA-induced hippocampal neurode-
generation in young animals, but IL-18 does not seem to
represent a key cytokine in this process in aged individu-
als.
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